Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are pleased to enclose herewith our Press Release relating to announcement of financial results for the quarter fourth quarter results on May 25, 2018 Thanking you,11-05-2018
11-05-2018
Board To Consider FY18 Results & Dividend On May 25, 2018
1.This is to inform you that a meeting of the Board of Directors of the Company will be held on Friday, May 25, 2018, inter alia, to transact following business: (i)To consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2018. (ii)To consider recommendation of dividend for the year ended March 31, 2018 subject to the approval of the shareholders at the ensuing Annual General Meeting....10-05-2018
Board Meeting On Friday, May 25, 2018
1.This is to inform you that a meeting of the Board of Directors of the Company will be held on Friday, May 25, 2018, inter alia, to transact following business: (i)To consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2018. (ii)To consider recommendation of dividend for the year ended March 31, 2018 subject to the approval of the shareholders at the ensuing Annual General...10-05-2018
Company news: Sun Pharma Consumer Healthcare
Sun Pharma Consumer Healthcare, a division of Sun Pharmaceutical Industries, has entered the anti-fungal powder OTC category with Abzorb. The brand wi30-04-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are pleased to enclose herewith our Press Release relating to Sun Pharma CHC enters anti-fungal powder OTC category with ABZORB, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you,30-04-2018
Compliance Certificate - Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2018
As per the requirements of Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herewith the Compliance Certificate dated 26th April, 2018 issued by M/S. KJB & Co. LLP, Practicing Company Secretaries, for the half year ended 31st March, 2018.26-04-2018
Compliance Certificate - Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2018
As per the requirements of Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herewith the Compliance Certificate dated 26th April, 2018 issued by M/S. KJB & Co. LLP, Practicing Company Secretaries, for the half year ended 31st March, 201826-04-2018
Today's picks: From Vedenta to Sun Pharma, hot stocks to watch on Tuesday
Keep a stop at Rs 1,465 and go short24-04-2018
Shareholding for the Period Ended March 31, 2018
Sun Pharmaceutical Industries Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here19-04-2018
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201518-04-2018